PDS Biotechnology Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PDS Biotechnology Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2014 to Q4 2023.
  • PDS Biotechnology Corp Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $56.6M, a 33.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $56.6M +$14.2M +33.6% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $42.4M +$11.9M +39% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $30.5M +$374K +1.24% Dec 31, 2021 10-K 2023-03-28
Q4 2020 $30.1M +$4.02M +15.4% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $26.1M +$20.9M +398% Dec 31, 2019 10-K 2021-03-18
Q4 2018 $5.25M -$45M -89.6% Dec 31, 2018 10-K 2020-03-27
Q4 2017 $50.3M +$10.5M +26.4% Dec 31, 2017 10-K 2019-02-21
Q4 2016 $39.8M +$18.1M +83.5% Dec 31, 2016 10-K 2018-03-01
Q4 2015 $21.7M +$11.7M +117% Dec 31, 2015 10-K 2017-03-02
Q4 2014 $9.98M Dec 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.